Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo

Journal of Experimental Medicine

Volumn 188, Issue 8, 1998, Pages 1535-1539

  Grimm, Stefan ^a,b   Weinstein, Edward J ^a   Krane, Ian M ^a,c   Leder, Philip ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c Genzyme Transgenics Corporation   (United States)

Author keywords

Apoptosis; Neu differentiation factor; Neuregulin; Tumors; TUNEL assay

Indexed keywords

FAS LIGAND; NEU DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CELL PROLIFERATION; CELL STRAIN BHK; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CRICETINAE; GLYCOPROTEINS; NEUREGULINS; ONCOGENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032547766     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.8.1535     Document Type: Article

References (15)

1. Grimm, S., and P. Leder. 1997. An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes. J. Exp. Med. 185:1137-1142.
2. Wen, D., E. Peles, R. Cupples, S.V. Suggs, S.S. Bacus, Y. Luo, G. Trail, S. Hu, S.M. Silbiger, R. Ben-Levy, et al. 1992. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell. 69:559-572.
3. Holmes, W.E., M.X. Sliwkoski, R.W. Akita, W.J. Henzel, J. Lee, J.W. Park, D. Yansura, N. Abadi, H. Paab, G.D. Lewis, et al. 1992. Identification of heregulin, a specific activator of p185 erbB2. Science. 256:1205-1209.
4. Krane, I.M., and P. Leder. 1996. NDF/Heregulin induced persistence of terminal end buds and adenocarcinomas in the mammary gland of transgenic mice. Oncogene. 12:1781-1789.
5. Jhappan, C., C. Stahle, R.N. Harkins, N. Fausto, G.H. Smith, and G.T. Merlino. 1990. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 61: 1137-1146.
6. Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 49:465-475.
7. Stewart, T.A., P.K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell. 38:627-637.
8. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119:493-501.
9. Koopman, G., C.P. Reutelingsperger, G.A. Kuiten, R.M. Keehen, S.T. Pals, and M.H. Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1415-1420.
10. Nagata, S., and P. Goldstein. 1995. The fas death receptor. Science. 267:1449-1455.
11. Chinnaiyan, A.M., C.G. Tepper, M.F. Seldin, K. O'Rourke, F.C. Kischkel, S. Hellbard, P.H. Krammer, M.E. Peter, and V.M. Dixit. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/Apo-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
12. Wen, D., S.V. Suggs, D. Karunagaran, D. Liu, R.L. Cupples, Y. Luo, A.M. Janssen, N. Ben-Baruch, D.B. Trollinger, V.L. Jacobson, et al. 1994. Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol. Cell Biol. 14: 1909-1919.
13. Chang, H., D.J. Riese, Jr., W. Gilbert, D.F. Stern, and U.J. McMahan. 1997. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature. 387:509-512.
14. Carraway, K.L., III, J.L. Weber, M.J. Unger, J. Ledesma, N. Yu, M. Gassmann, and C. Lai. 1997. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature. 387:512-516.
15. Baulida, J., M.H. Krauss, M. Alimandi, P.P. Di Fiores, and G. Carpenter. 1996. All erbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271:5251-5257.